Ginsenoside Rg3: Potential Molecular Targets and Therapeutic Indication in Metastatic Breast Cancer.

Nakhjavani, Maryam; Hardingham, Jennifer E; Palethorpe, Helen M; Tomita, Yoko; Smith, Eric; Price, Tim J; Townsend, Amanda R

Nakhjavani, Maryam; Hardingham, Jennifer E; Palethorpe, Helen M; Tomita, Yoko; Smith, Eric; Price, Tim J; Townsend, Amanda R.

Afiliación

Nakhjavani M; Molecular Oncology, Basil Hetzel Institute, The Queen Elizabeth Hospital, Woodville South, SA 5011, Australia. maryam.nakhjavani@adelaide.edu.au.
Hardingham JE; Adelaide Medical School, University of Adelaide, Adelaide, SA 5005, Australia. maryam.nakhjavani@adelaide.edu.au.
Palethorpe HM; Molecular Oncology, Basil Hetzel Institute, The Queen Elizabeth Hospital, Woodville South, SA 5011, Australia. jenny.hardingham@sa.gov.au.
Tomita Y; Adelaide Medical School, University of Adelaide, Adelaide, SA 5005, Australia. jenny.hardingham@sa.gov.au.
Smith E; Molecular Oncology, Basil Hetzel Institute, The Queen Elizabeth Hospital, Woodville South, SA 5011, Australia. helen.palethorpe@adelaide.edu.au.
Price TJ; Adelaide Medical School, University of Adelaide, Adelaide, SA 5005, Australia. helen.palethorpe@adelaide.edu.au.
Townsend AR; Molecular Oncology, Basil Hetzel Institute, The Queen Elizabeth Hospital, Woodville South, SA 5011, Australia. yoko.tomita@adelaide.edu.au.

Medicines (Basel) ; 6(1)2019 Jan 23.

Article en En | MEDLINE | ID: mdl-30678106

Palabras clave

AQP-1; Ginsenoside Rg3; angiogenesis; breast cancer; epimer

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Medicines (Basel) Año: 2019 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google